(Q43577849)

24 November 2017

title

The effects of hormone replacement therapy on lipid peroxidation and antioxidant status (English)

1 reference

Hormone Replacement Therapy

24 November 2017

main subject

1 reference

Ozden S

1

1 reference

24 November 2017

Dildar K

series ordinal

2

1 reference

24 November 2017

Kadir YH

series ordinal

3

1 reference

24 November 2017

Gülizar K

series ordinal

4

1 reference

24 November 2017

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

38

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

165-170

1 reference

Menopause and risk of cardiovascular disease: the Framingham study.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Postmenopausal use of estrogen and occlusion of coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

The role of free radicals in toxicity and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Red cell peroxide metabolism in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Microsomal lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Oestrogens and atherosclerotic vascular disease--lipid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Lipid peroxidation and its role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

The Susceptibility to Autoxidation of Human Red Cell Lipids in Health and Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Estrogens inhibit copper and cell-mediated modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Effect of combined 17β-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Estrogens as natural antioxidants of membrane phospholipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Are the antioxidative effects of 17 beta-estradiol modified by concomitant administration of a progestin?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

Effects of hormone replacement therapy on plasma nitric oxide and total thiol levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900216-4

7 January 2021

10.1016/S0378-5122(00)00216-4

Identifiers

DOI

1 reference

24 November 2017

1 reference